Published in Free Radic Biol Med on May 10, 2007
A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One (2008) 3.25
Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol (2009) 2.65
Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys (2010) 1.91
Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol (2009) 1.85
What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One (2011) 1.74
Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev (2013) 1.44
Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol (2009) 1.44
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med (2008) 1.36
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis (2011) 1.31
Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol (2012) 1.26
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des (2013) 1.22
Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.19
RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes (2008) 1.18
Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation (2010) 1.16
Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal (2009) 1.14
Dose-dependency of resveratrol in providing health benefits. Dose Response (2010) 1.11
Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol (2010) 1.09
Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal (2009) 1.08
Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. J Agric Food Chem (2008) 1.04
The PGC-1 cascade as a therapeutic target for heart failure. J Mol Cell Cardiol (2010) 1.04
Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr (2012) 1.02
Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev (2012) 1.01
Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol Dis (2009) 1.00
Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J Cell Mol Med (2014) 1.00
Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann N Y Acad Sci (2011) 0.98
Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol (2010) 0.98
Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radic Biol Med (2008) 0.98
Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PLoS One (2013) 0.98
Low oxygen tension positively influences cardiomyocyte progenitor cell function. J Cell Mol Med (2011) 0.97
Targeting the mitochondria to augment myocardial protection. Curr Opin Pharmacol (2008) 0.97
Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats. J Biomed Biotechnol (2011) 0.97
In vitro inhibition activity of polyphenol-rich extracts from Syzygium aromaticum (L.) Merr. & Perry (Clove) buds against carbohydrate hydrolyzing enzymes linked to type 2 diabetes and Fe(2+)-induced lipid peroxidation in rat pancreas. Asian Pac J Trop Biomed (2012) 0.96
Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem (2011) 0.95
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J Diabetes Investig (2014) 0.94
Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina. Diabetes (2010) 0.94
Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium. J Cell Mol Med (2011) 0.94
Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants. Curr Cardiol Rev (2008) 0.93
Oxidative stress in heart failure: what are we missing? Am J Med Sci (2011) 0.92
Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme oxygenase. Oxid Med Cell Longev (2013) 0.90
Amelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1. Biomed Res Int (2014) 0.90
Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats. PLoS One (2012) 0.89
Mitochondrial therapeutics for cardioprotection. Curr Pharm Des (2011) 0.89
Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid Med Cell Longev (2013) 0.89
Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice. Diabetologia (2015) 0.88
Ca2+/calmodulin-dependent protein kinase kinase β phosphorylation of Sirtuin 1 in endothelium is atheroprotective. Proc Natl Acad Sci U S A (2013) 0.88
SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats. Cardiovasc Diabetol (2015) 0.88
Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats. J Neural Transm (Vienna) (2013) 0.85
Endothelial Nrf2 activation: a new target for resveratrol? Am J Physiol Heart Circ Physiol (2010) 0.84
Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats. J Physiol (2014) 0.84
Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.84
Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart Circ Physiol (2011) 0.84
Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice. Nutr Metab (Lond) (2014) 0.83
Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathway. J Biomed Biotechnol (2010) 0.82
Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol. PLoS One (2014) 0.82
Resveratrol attenuates azidothymidine-induced cardiotoxicity by decreasing mitochondrial reactive oxygen species generation in human cardiomyocytes. Mol Med Rep (2010) 0.82
Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart. J Cell Mol Med (2008) 0.81
Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxid Redox Signal (2008) 0.81
Resveratrol prevents interleukin-1β-induced dysfunction of pancreatic β-cells. J Biomed Res (2010) 0.81
Pharmacometrics of 3-methoxypterostilbene: a component of traditional chinese medicinal plants. Evid Based Complement Alternat Med (2013) 0.81
Effects of Short-term Renovascular Hypertension and Type 2 Diabetes on Cardiac Functions in Rats. Iran J Med Sci (2014) 0.80
Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice. J Nutr (2014) 0.80
How exercise may amend metabolic disturbances in diabetic cardiomyopathy. Antioxid Redox Signal (2015) 0.80
Differential gene expression in liver tissues of streptozotocin-induced diabetic rats in response to resveratrol treatment. PLoS One (2015) 0.79
The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise. Antioxid Redox Signal (2015) 0.78
Resveratrol prevents cardiovascular complications in the SHR/STZ rat by reductions in oxidative stress and inflammation. Biomed Res Int (2015) 0.78
Experimental Diabetes Mellitus in Different Animal Models. J Diabetes Res (2016) 0.77
Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art. Biomed Res Int (2015) 0.77
Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR‑γ/HO‑1 pathways. Mol Med Rep (2016) 0.75
Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim (2014) 0.75
At the interface of antioxidant signalling and cellular function: Key polyphenol effects. Mol Nutr Food Res (2016) 0.75
Effect of Lycopene on Serum Nitrite-Nitrate Levels in Diabetic Rats. Indian J Pharm Sci (2015) 0.75
Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility. J Diabetes Res (2016) 0.75
Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension. Biomed Res Int (2015) 0.75
Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury. Mol Med Rep (2016) 0.75
Resveratrol Inhibition of Cellular Respiration: New Paradigm for an Old Mechanism. Int J Mol Sci (2016) 0.75
The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System. Oxid Med Cell Longev (2017) 0.75
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
Thioredoxin. Annu Rev Biochem (1985) 9.82
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem (2000) 7.25
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation (2006) 5.50
Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J (1988) 5.24
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest (1994) 3.51
Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest (1996) 3.42
Redox regulation of cellular activation. Annu Rev Immunol (1997) 3.17
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol (1999) 3.15
Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry (1982) 2.93
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59
The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal (2005) 2.46
Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes (2006) 2.12
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol (2006) 1.94
Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med (1999) 1.84
Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol (1998) 1.69
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation (2002) 1.67
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol (2005) 1.59
Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci (2005) 1.54
Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res (1999) 1.44
Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J (2004) 1.38
Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol (1998) 1.31
Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med (1998) 1.30
Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem (2004) 1.23
Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes. J Biol Chem (2003) 1.22
Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol (2001) 1.19
Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes (2005) 1.15
Retracted Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.13
Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys (2006) 1.12
The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med (1991) 1.12
Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr (1997) 1.09
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol (2004) 1.09
Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin Sci (Lond) (2000) 1.03
Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun (2004) 1.02
Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol (1998) 1.02
Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett (2000) 1.00
A protective role for heme oxygenase-1 in INS-1 cells and rat islets that are exposed to high glucose conditions. J Korean Med Sci (2006) 0.98
High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia (2001) 0.98
Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J (1995) 0.97
Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res (1995) 0.95
Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res (2001) 0.94
Niacin-bound chromium enhances myocardial protection from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2006) 0.94
Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. J Clin Endocrinol Metab (1996) 0.93
Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc Soc Exp Biol Med (1994) 0.89
Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung (1999) 0.89
Redox regulation of NF-kappaB and AP-1 in ischemic reperfused heart. Antioxid Redox Signal (1999) 0.86
Heme oxygenase-1 induction by endogenous nitric oxide: influence of intracellular glutathione. FEBS Lett (2003) 0.85
Influence of heme oxygenase-1 gene transfer on the viability and function of rat islets in in vitro culture. World J Gastroenterol (2007) 0.84
Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid (2012) 2.78
Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res (2007) 2.30
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol (2006) 1.94
Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol (2004) 1.93
Retracted Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2006) 1.77
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol (2003) 1.75
What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One (2011) 1.74
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. J Pharmacol Exp Ther (2006) 1.71
Retracted Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J Mol Cell Cardiol (2006) 1.70
Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol (2010) 1.64
Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets (2007) 1.63
Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways. J Pharmacol Exp Ther (2005) 1.62
Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc Natl Acad Sci U S A (2002) 1.60
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol (2005) 1.59
Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation (2004) 1.58
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res (2008) 1.55
Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med (2008) 1.54
Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann N Y Acad Sci (2002) 1.54
Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation. Am J Physiol Heart Circ Physiol (2005) 1.53
Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res (2003) 1.53
Retracted Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol. J Cell Mol Med (2006) 1.50
Retracted Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium. J Cell Mol Med (2007) 1.48
Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv (2006) 1.48
Redox signaling in vascular angiogenesis. Free Radic Biol Med (2002) 1.45
Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase. Circ J (2010) 1.44
Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal (2005) 1.40
Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res (2009) 1.40
Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol (2009) 1.32
Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol (2005) 1.32
Retracted Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem (2008) 1.31
Resveratrol and chemoprevention. Cancer Lett (2009) 1.31
Autophagy, redox signaling, and ventricular remodeling. Antioxid Redox Signal (2009) 1.28
Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr (2002) 1.26
Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov (2007) 1.24
Molecular mechanism of preconditioning. IUBMB Life (2008) 1.23
Retracted Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med (2008) 1.22
Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1. J Cell Mol Med (2008) 1.21
Cardioprotection by endoplasmic reticulum stress-induced autophagy. Antioxid Redox Signal (2011) 1.21
Cardiac genomic response following preconditioning stimulus. Cardiovasc Res (2006) 1.18
Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One (2010) 1.17
Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol (2005) 1.16
Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation (2010) 1.16
Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol (2009) 1.16
Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol (2003) 1.13
Retracted Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.13
Multidimensional normative ratings for the International Affective Picture System. Behav Res Methods (2007) 1.13
Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys (2006) 1.12
Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease--an overview. Toxicol Mech Methods (2012) 1.11
Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim Biophys Acta (2008) 1.11
Dose-dependency of resveratrol in providing health benefits. Dose Response (2010) 1.11
Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol (2007) 1.11
Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci (2011) 1.10
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am J Physiol Heart Circ Physiol (2007) 1.10
Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem (2002) 1.10
Retracted Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res (2006) 1.09
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol (2004) 1.09
Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice. Antioxid Redox Signal (2011) 1.08
Retracted Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol (2005) 1.08
Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal (2009) 1.08
GATA-4 regulation of myocardial survival in the preconditioned heart. J Mol Cell Cardiol (2004) 1.08
Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J (2003) 1.08